// STATE LEGISLATION TRACKER

Tennessee HB 877: Pharmacy, Pharmacists - As enacted, makes changes with regard to compounding pharmacies, including allowing out-of-state

⚖️ MIXED for peptide users 👤 MEDIUM user impact 📜 Status: Signed

State: Tennessee
Bill: HB 877
Filed: 2021-02-09
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Tennessee HB877 updates rules for compounding pharmacies, especially out-of-state pharmacies serving Tennessee patients. It allows the Tennessee Board of Pharmacy to accept equivalent recent inspections and removes a quarterly reporting requirement for sterile compounding pharmacies.

Key Points

Out-of-state compounders may have an easier path to Tennessee licensure or renewal.
Sterile compounding pharmacies face less routine reporting to the board.
The board still controls whether an equivalent inspection is acceptable.
This affects compounded peptide access more than prescribing rules.
No clear change to telehealth, NP scope, naturopathic scope, or controlled substances.

What to Watch For

✓

Opportunity Could make it easier for licensed out-of-state compounding pharmacies to serve Tennessee peptide patients.

Concern Less routine sterile-compounding reporting may reduce visibility into volume and oversight trends.

Note Access depends on how the Tennessee Board of Pharmacy applies its inspection-acceptance standard.

Where the Bill Stands

The bill was enacted as Public Chapter 149 and became effective on April 13, 2021.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-10-02 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws